Institutional investors hold a majority ownership of ZTS through the 96.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2017, these large investors purchased a net $1.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY INVESTMENT MANAGE... Bought 9.5 Million shares of Zoetis Inc
WADDELL & REED INVESTMENT MANAGE... Bought 2.2 Million shares of Zoetis Inc
BLACKROCK FUND ADVISORS Bought 1.6 Million shares of Zoetis Inc